1 1920X1080



Structural Precision
Then Evolving Refinement


Model is not an actual patient.

Discover why Ellansé is the Secret to
Facial Rejuvenation

How ELLANSÉ is different

Immediate Reshape & Refinement

Experience an instant lift in your facial contours while starting a deep transformation of your skin’s quality.
2 900X900 2
Model is not an actual patient.

Lasting Results

Ellansé is designed for longevity, not just a moment. Enjoy structural support and visible refinement that stays with you for up to 24 months.*
22 900X900 2

Actual results depend on the specific variant used,
practitioner’s injection technique, as well as individual factors
such as lifestyle, age, and metabolic rate.
Model is not actual patient.

Regenerative Safety

Ellansé re-awakens your skin’s own collagen production. Both components of Ellansé, CMC and PCL, can be naturally broken down by the body and then eliminated.
2 900X900 1
Model is not an actual patient.
3 Light

Structured Support.
Refined Beauty.

${ item.title }

${ item.title }

${ item.text } > ${ item.cta.name }
Model is not an actual patient.
I have been using Ellansé for 8 years and performed many treatments during this time: I love seeing the benefits of working with such a versatile product.
Shang Li Min

Find your clinic

Search your location or postcode.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

 

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

 

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Corporate Safety Group: quality@sinclair.com

For a full list of contraindications, warnings, and precautions for this product please visit here for a copy of the Product Instructions for Use.